Benzinga | May 6, 2021 08:11AM EDT

Antares Pharma Q1 EPS $0.02 Beats $0.01 Estimate, Sales $42.08M Beat $38.47M Estimate

Antares Pharma (NASDAQ:ATRS) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $0.01 by 100 percent. This is a 300 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $42.08 million which beat the analyst consensus estimate of $38.47 million by 9.39 percent. This is a 27.22 percent increase over sales of $33.08 million the same period last year.